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Delayed, tuberculin-type reactions to intra-
dermal procaine can be elicited in patients who
develop local allergic edema of the subcutaneous
tissues twelve to twenty-four hours following the
injection of procaine for regional anesthesia. This
type of reaction to procaine or chemically re-
lated local anesthetic agents was first described
by Adler and Simon in 1949 (1), and its allergic
nature was discussed in later reports by Mitchell
(2) and by Siegal (3). Clinically, local allergic
edema due to procaine is seen most frequently
in dental practice where the affected patient de-
velops massive swelling of the soft tissues of the
face and cheek on the day following infiltration
of the gums with procaine. Similar local reactions
are seen after the injection of procaine for minor
surgical procedures in any part of the body, or
following the injection of procaine penicillin.
The intradermal skin test response to procaine
in these patients has all the gross characteristics
of the tuberculin reaction: it first appears about
four to five hours after the injection of antigen,
reaches its maximum intensity in twelve to
thirty-six hours, consists of an area of induration
surrounded by erythema which at times is pru-
ritic and eczematous in appearance, and may in
extremely sensitive cases proceed to central nec-
rosis and sloughing. Of the patients with delayed
type intradermal reactions to procaine, only
forty per cent have positive patch tests to pro-
caine (4). The remainder have positive intra-
dermal tests but negative patch tests.
Delayed type cutaneous hypersensitivity to
procaine is not clinically related to anaphylactic
procaine allergy, nor can circulating antibodies
to procaine be demonstrated in these cases (2, 3).
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The delayed type of intradermal reaction merely
reflects a capacity of the skin and subcutaneous
tissues to become edematous in the presence of
procaine. In the absence of demonstrable circu-
lating antibodies, it can reasonably be assumed
that the antibodies or antibody-like substances
responsible for delayed local allergic tissue edema
to procaine are cellular in type.
Landsteiner and Chase in 1942 (5) were the
first to develop a simple technic for the passive
cellular transfer of delayed type hypersensi-
tivity in animals. In man, Lawrence (6, 7)
showed that if living leukocytes or extracts of
leukocytes isolated from the peripheral blood of
donors sensitive to tuberculin were injected
intradermally into tuberculin negative recipients,
the recipients became temporarily tuberculin-
positive. In his experiments, the hypersensitivity
of the recipient to tuberculin was not restricted
to the site of transfer but could be demonstrated
over the entire body surface for a period of
several weeks to several months. Further reports
by Lawrence and others have shown that de-
layed type hypersensitivity to additional mi-
crobial antigens such as streptococcal M-sub-
stance (8), diphtheria toxin (9), cat scratch
antigen (10) and coccidiodin (11) can be trans-
ferred in the same fashion.
Delayed type hypersensitivity to microbial
antigens as detected by intradermal testing has
thus been passively transferred in humans by
several investigators using different methods and
different antigens. On the other hand, attempts
to transfer delayed type hypersensitivity to
simple chemical substances in humans have, in
general, produced much less consistent results.
Urbach, in 1925 (12) reported the first successful
passive transfer of contact allergy to simple
chemical substances. By transferring fluid from
the cutaneous blisters of patients suffering from
allergic dermatoses, he was able to induce de-
layed type hypersensitivity to the offending sub-
stance at the transfer sites in normal recipients.
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If no naturally occurring blisters were present,
they were intentionally raised by the appli-
cation of cantharides plasters. In subsequent
investigations, some workers were able to con-
firm his results, whereas others were unable to
obtain successful transfers using the same tech-
nic (13).
Prior to 1957, attempts to transfer delayed
type hypersensitivity to simple chemical sub-
stances with peripheral blood leukocytes rather
than blister fluid produced equally inconclusive
results (14, 15, 16). However, Epstein and Klig-
man in 1957 (17) reported consistently successful
transfers of delayed type contact hypersensi-
tivity to pentadecyl catechol, 2 ,4-dinitrochloro-
benzene, and paranitrosodimethyl aniline. Re-
cipient hypersensitivity was induced with viable
leukocytes, with untreated blister fluid, with cell
free blister fluid or with whole blood trans-
fusions. Good (18) in the same year reported the
successful transfer of delayed type contact hyper-
sensitivity to 2 ,4-dinitrochlorobenzene with
viable leukocytes
In a more recent investigation, Harber and Baer
(19) found that they were unable to passively
transfer allergic eczematous contact sensitivity
to 2, 4-dinitrochlorobenzene in humans with
whole blood transfusions. As an explanation for
their findings, they suggest that there may be
fundamental immunological differences between
tuberculin-type and contact-type eczematous
sensitivity.
It is of interest to note that all of the studies
so far cited utilized patch testing for the de-
tection of delayed type cutaneous hypersensi-
tivity to simple chemical substances. The only
investigation in which intradermal testing was
used was that of Haxthausen (20). In his experi-
ments, lymphocyte suspensions prepared from
the excised lymph nodes of patients suffering
from allergic dermatoses were transferred intra-
dermally to previously normal recipients. When
the transfer sites were challenged by patch test-
ing, no positive reactions were found. However,
when similarly prepared transfer sites were tested
by the intradermal injection of antigen, positive
delayed type reactions were obtained in most
cases.
The purpose of the present investigation was
to determine whether delayed type cutaneous
hypersensitivity to intradermal procaine could
be passively transferred by viable leukocytes and
by leukocyte extracts.
METHODS AND MATERIALS
Separation of Viable Leukocytes: (The method
used was a modification of the technic of Minor
and Burnett) (21). Bovine fibrinogen (fraction 1,
Armour) was used to accelerate the erythrocyte
sedimentation rate of sensitive donors. One
hundred ml. of whole venous blood was obtained
from each donor. The blood was drawn into 50 ml.
syringes which had been previously rinsed with
heparin (10 mg. per ml). It was then transferred
in 25 ml. quantities to test tubes, each containing
3 ml. of fibrinogen solution (45 mg. per ml.). The
tubes were inverted several times to ensure com-
plete mixing. The mixture of blood, heparin and
fibrinogen was next transferred in 10 ml. quantities
to conical centrifuge tubes which were placed at
an angle of 60 degrees to the horizontal in a water
bath at 37° C. Sedimentation of erythrocytes
began in about five minutes and was completed
in approximately thirty minutes. As sedimenta-
tion proceeded, the suspension of leukocytes in
plasma which was formed above the erythrocytes
was gently pipetted away at three minute intervals
and transferred to graduated capillary tip centri-
fuge tubes. The cell suspensions thus obtained
were centrifuged at 1500 r.p.m. for fifteen minutes.
The supernatant plasma was decanted. The cells
were packed in a single capillary tip centrifuge
tube and washed twice with normal saline. Follow-
ing washing and recentrifugation, a layer of
erythroeytes was seen to be present at the bottom
of the tube below the leukocytes. These were
removed by aspiration through an 18 gauge spinal
puncture needle. The final yield was 0.30—0.45 ml.
of washed packed leukocytes per 100 ml. of venous
blood. For injection the entire yield of leukocytes
was suspended in 2 ml. of normal saline. Sterile
precautions were observed throughout, and all
glassware was siliconized.
Preparation of Leukocyte Extracts by Freezing
and Thawing: The packed leukocytes obtained
from 100 ml. of venous blood were suspended in
2 ml. of normal saline in a test tube which was
alternately immersed in a bath of dry ice and iso-
propyl alcohol at 70° C, and in a water bath at
37° C. The freezing and thawing procedure was
repeated ten times. The preparation was then
centrifuged at 1500 r.p.m. for fifteen minutes.
The supernatant leukocyte extract was decanted
and retained for injection.
Preparation of Leukocyte Extracts by Sonic
Vibration: The packed leukocytes obtained from
100 ml. of venous blood were suspended in 2 ml.
of normal saline in a test tube which was subjected
to sonic vibration at 45 kiloeycles per second for
seven minutes. (Branson AP-10-B generator with
T-32 transducer.) The preparation was then
centrifuged at 1500 r.p.m. for fifteen minutes. The
supernatant leukocyte extract was decanted and
retained for injection.
Microscopic Examination: Microscopic exami-
nation of the viable leukocyte preparations
showed about fifteen per cent contamination with
erythrocytes. Seventy-five to eighty per cent of
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the leukocytes were seen to be viable on supravital
staining with methyl red and Janus green. The
freezing and thawing and sonic vibration proce-
dures produced complete structural disintegration
of the leukocytes as determined by microscopic
inspection.
Technic of Passive Transfer: The suspensions of
viable leukocytes or leukocyte extracts were
injected intradermally in the upper arm of the
recipients. The entire yield from 100 ml. of donor
blood was given to each recipient. Because the 2
ml. volume of viable leukocyte suspensions or
leukocyte extracts was too great for a single
injection, four intradermal injections of 0.5 ml.
were given in adjacent sites. There was a minimal
amount of local inflammatory reaction which
usually subsided in twenty-four hours.
Skin Testing: Skin testing was performed by
the intradermal injection of 0.1 ml. of antigen
through a 26 gauge hypodermic needle. The test
sites were inspected in 6, 24 and 48 hours. The
size of the skin test reaction was recorded in
millimeters by measuring right angled diameters
of induration and erythema at the time of maxi-
mum intensity. Any reaction greater than 5 mm.
X 5 mm. was considered to constitute a positive
test.
EXPERIMENTAL PROCEDURES AND RESULTS
Cellular Transfer of Delayed Cutaneous Hyper-
sensitivity to Procaine with Viable Leukocytes:
Eight patients with a history of local allergic
edema due to injected procaine, and showing
strongly positive delayed type skin reactions to
procaine, were selected as leukocyte donors. The
recipients were healthy young adults who were
shown to have negative intradermal skin tests to
procaine prior to the transfer experiments.
Eleven passive transfers of viable leukocytes
from procaine sensitive donors to procaine nega-
tive recipients were performed. (Three of the
procaine sensitive patients were used as donors
on two occasions). The recipients were tested
with intradermal procaine at the site of injection,
and on the volar surface of the opposite forearm
at intervals of two, four, seven and sixty days
after transfer.
The results of skin testing the recipients with
procaine following the transfer of viable cells are
summarized in Table 1. It will be seen that six
of eleven previously normal recipients developed
temporarily positive delayed type skin reactions
to procaine. The hypersensitivity of the recipi-







aEsuLTS or PASSIVE TRANSFERS WITH VIABLE LEuscocvTEs
Donor's Skin Recipients' Skin Tests to Procaine (mm.)
Test to
Donor Procaine (mm.) Recipient QsxJ Psx..i P31..! P3i..Q
B.A. 10x12 F.R. 5,c5 10x10 lOxlO Neg.
H.A. 30 x 20 R.F. Neg. Neg. Neg. Neg.
O.R. 45 x 25 F.!. 5 x S 10 x 10 10 x 10 12 x 10
O.R. 45x25 B.O. 7x7 5x S — —
H.O. 35 x 30 G.R. Neg. Neg. Neg. Neg.
B.R. 15 x 15 H.A. Neg. Neg. Neg. Neg.
S.T. 40 x 35 P.E. Neg. Neg. Neg. Neg.
S.T. 40x35 B.!!. Neg. Sz S - —
R.I. 35 x 25 E.D. Neg. Neg. Neg. Neg.
R.I. 35x25 F.A. Neg. lix 5 iOxlO —
C.U. SOxSO 2CR. 3x3 lix 6 lOx 9 Neg.
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of transfer, but, in each ease, was also present
in the skin of the opposite arm.
With the exception of donor BA., the leuko-
cytes obtained from donors showing the largest
skin reactions produced the greatest degree of
recipient hypersensitivity. The importance of a
recipient factor governing the outcome of the
transfer is illustrated by the fact that cells taken
from donors R.I. and ST. produced a transfer
in one recipient, but not in another. The average
duration of the transferred hypersensitivity is
difficult to estimate from the data available. Un-
fortunately, only three of six positive recipients
were available for testing at sixty days. Of these,
only one was positive at sixty days.
Attempts at the passive transfer of procaine
hypersensitivity with plasma were unsuccessful.
Cellular Transfer of Delayed Cutaneous Hyper-
sensitivity to Procaine with Leulcocyte Extracts:
The passive transfer experiments were repeated
using leukocyte extracts prepared by freezing
and thawing or by sonic vibration. Five of the
eight procaine sensitive patients used in the pas-
sive transfer experiments with viable leukocytes
again acted as leukocyte donors. (Tables 2 and
3). Three of these five leukocyte donors (O.R.,
RI. and G.U.) had produced successful transfers
with viable leukocytes.
The results of the cell extract transfers are
summarized in Tables 2 and 3. The tables show
that, following the intradermal injection of leu-
kocyte extracts obtained from procaine positive
patients, two out of six previously normal recipi-
ents developed temporarily positive delayed type
skin reactions to procaine. As with the viable
leukocytes, the transferred cutaneous hypersensi-
FIG. 2 Delayed intradermal reaction (10 mm. X
10 mm.) to procaine in previously normal recipient
FT. ten days following transfer of viable cells from
donor O.R.
TABLE 2
RESULTS OF PASSIVE TRANSFERS WITH LEUXOCYTE EXTRACTS
PREPARED BY SONIC VIBRATION
Donor's Skin Recipients' Skin Tests to Procaine (mm.)
Test to
Donor Procaine (mm.) Recipient pj
G.U. S0x50 L.O. 6x10 6x10 Neg.
R.I. 35 x 25 N.E. Neg. Neg. Neg. Neg.
H.A. 30 x 20 H.Y. Neg. Neg. Neg. Neg.
TABLE 3
RESULTS OF PASSIVE TRANSFERS WITH LEUKOCYTE EXTRACTS
PREPARED BY FREEZING AND THAWING
Donor's Skin Recipients' Skin Tests to Procaine (mm.)
Test to
Donor Procaine (mm.) Recipient Pai... Qy.i Qar.i Pai.29
O.R. 45 x 25 G.O. Neg. Neg. Neg. Neg.
R.I. 35 x 25 T.H. 5 x 8 Neg. Neg. Neg.
H.O. 35 x 30 I.N. Neg. Neg. Neg. Neg.
Beg.
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tivity was also present in the arm opposite to
the transfer site. The leukocyte extracts in the
two successful transfers were obtained from
donors whose viable cells had also produced posi-
tive cellular transfers. One of these extracts was
prepared by sonic vibration, (G.U.), and one by
freezing and thawing (R.I.). The greater degree
of transferred sensitivity to procaine was found
in the recipient who had received an extract pre-
pared from the leukocytes of the most sensitive
donor (G.U.).
CONCLUSIONS
Epstein and Kligman (17) attributed their
success in transferring delayed type contact (i.e.
patch test) allergy to simple chemical substances
to the use of large amounts ef leukocytes ob-
tained from exquisitely sensitive donors. They
also found the chemical configuration of the
antigen to be of importance in determining the
success of the transfer. In the present investi-
gation, the donors were only moderately sensi-
tive, relatively small volumes of leukocytes were
used in the transfers, and procaine is not by
reputation an extremely potent sensitizer. Never-
theless, six positive transfers of delayed type
hypersensitivity to procaine were obtained in
eleven attempts with viable cells. A possible ex-
planation for these findings is that intradermal
testing may be a more sensitive method than
patch testing for detecting eellularly transferred
delayed type hypersensitivity.
Thus, it is of interest that intradermal testing
is always employed in the detection of cellularly
transferred delayed type hypersensitivity to mi-
crobial antigens, whereas patch testing is tra-
ditionally utilized in transfer studies with simple
chemical substances. If it is assumed that intra-
dermal testing is more sensitive than patch
testing, then the consistently successful cellular
transfers obtained with microbial antigens, and
the highly variable results obtained with simple
chemical substances, might be explained as a
function of the method ef testing for delayed
type cutaneous hypersensitivity. The validity of
this hypothesis is supported by the experiments
of Haxthausen (20) in which it was found that
transferred delayed type hypersensitivity to
simple chemical substances was detectable by
intradermal testing, but not by patch testing.
Under the conditions ef the present study, the
advantages of intradermal testing are clearly
demonstrated by the observation that only forty
per cent of patients with local allergic edema due
to procaine show positive patch tests to procaine
in contrast to the one hundred per cent reaction
rate with intradermal testing (4). Perhaps intra-
dermal tests, where feasible, should be used more
frequently than they are at present in the diag-
nosis of allergic contact dermatitis.
In eases of delayed type hypersensitivity to
procaine, the method by which the antigen is
brought into contact with the sensitized tissue
greatly influences the nature of the ensuing al-
lergic response. Repeated contact of the epi-
dermis with procaine as occurs, for instance, in
sensitized physicians produces an eczematous
dermatitis. Repeated subcutaneous injection, on
the other hand, results in local allergic tissue
edema in susceptible individuals. The phe-
nomenon of local allergic tissue edema would
undoubtedly occur with simple chemical sub-
stances other than procaine (or chemically re-
lated local anesthetic agents) were they ad-
ministered in the same way as procaine or its
analogs. This class of drugs is unique in that
they are among the very few simple chemical
substances in modern medicine which are fre-
quently and repeatedly injected subcutaneously
in the same individual.
An analogous type of reaction occurs with the
microbial antigens contained in bacterial vac-
cines. Patients suffering from bronchial asthma
due to bacterial hypersensitivity who are given
subcutaneous injections of bacterial vaccine will
frequently develop delayed allergic edema of the
subscutaneous tissues at the site of injection.
This reaction is grossly indistinguishable from
allergic tissue edema due to procaine. Further-
more, intradermal testing with the vaccine re-
sponsible for the allergic tissue edema will in-
variably produce a delayed type cutaneous
reaction.
A successful transfer of delayed type hyper-
sensitivity with the cell-free supernatant from
cells disrupted by sonic vibration has not previ-
ously been reported in humans. In guinea-pigs,
however, Jeter, Tremaine and Seebohm (22) have
reported the transfer of delayed hypersensitivity
to 2 ,4-dinitroehlorobenzene with extracts of leu-
kocytes prepared by sonic vibration. In the
present investigation, delayed type hypersensi-
tivity to procaine was transferred in one of three
attempts with leukoeyte extracts prepared by
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sonic vibration. The success of the transfer in
this one case may have been due to the sensi-
tivity of intradermal testing, or perhaps to the
fact that the cell donor used was the most al-
lergic to procaine in the entire series. It should
be remembered that passive cellular transfers of
delayed type hypersensitivity have so far been
obtained in humans with viable leukocytes (6),
with leukocytes disrupted by freezing and thaw-
ing (5, 23), with cell-free supernatants separated
from cells disrupted by freezing and thawing,
(8, 23) and with cell-free blister fluid (24). The
so-called cell-free fluids used in cellular transfer
studies must contain leukocyte fragments of un-
known size which are responsible for the trans-
fer. There is, therefore, no theoretical reason
why cell fragments prepared by sonic vibration
cannot produce similar results under suitable
experimental conditions.
Delayed type hypersensitivity to procaine was
also transferred by cell extracts prepared from
lcukocytes disrupted by freezing and thawing.
This finding is in keeping with previously re-
ported results on the transfer of delayed cu-
taneous hypersensitivity to microbial antigens.
sUMMARY
Delayed tuberculin type intradcrmal reac-
tions to procaine are found in patients who de-
velop allergic edema of the subcutaneous tissues
twelve to twenty-four hours after local infil-
tration with procaine. The purpose of this study
was to find out if delayed cutaneous hypersensi-
tivity to the intradermal injection of procaine
could be passively transferred by viable leuko-
cytcs, and by leukocyte extracts.
Eight patients with a history of allergic sub-
cutaneous edema due to procaine and strongly
positive delayed type intradermal reactions to
procaine were selected as donors. Living leuko-
cytcs (0.3—0.4 ml.) were isolated from the pe-
ripheral blood of each of the donors and injected
intradermally in individual procaine negative
recipients. When the recipients were tested with
intradermal procaine following the transfer, six
out of eleven developed positive delayed type
skin reactions to procaine.
When the experiments were repeated using
cell-free leukocyte extracts prepared by freezing
and thawing or by sonic vibration, successful
transfers were obtained in two out of six cases.
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